Literature DB >> 12582738

Nosocomial and community-acquired spontaneous bacterial peritonitis: comparative microbiology and therapeutic implications.

F Bert1, M Andreu, F Durand, F Degos, J-O Galdbart, R Moreau, C Branger, N Lambert-Zechovsky, D Valla.   

Abstract

In order to compare the microbiological characteristics of nosocomial and community-acquired episodes of bacterial peritonitis, 95 consecutive, spontaneous episodes were reviewed. Seventy of these episodes were bacteriologically documented. Fifty-three (55.8%) episodes were nosocomial and 42 (44.2%) were community acquired. A total of 78 pathogens were isolated, including 40 gram-positive cocci (34 streptococci, 6 Staphylococcus aureus), 35 gram-negative bacilli (including 23 Escherichia coli), 2 gram-positive bacilli and 1 yeast. Streptococci were found more frequently in community-acquired episodes (53.8%) than in nosocomial episodes (33.3%). Gram-negative bacilli were significantly more frequent in nosocomial episodes than in community-acquired episodes (56.4% vs. 33.3%, P<0.05). Nosocomial isolates were significantly more resistant to amoxicillin-clavulanic acid (48.7% vs. 18.4%, P<0.01) and cefotaxime (33.3% vs. 13.2%, P<0.05) than community-acquired isolates, but no difference was detected regarding resistance to ciprofloxacin. The results indicate that the empirical treatment of spontaneous bacterial peritonitis should differ for nosocomial and community-acquired cases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12582738     DOI: 10.1007/s10096-002-0840-z

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  24 in total

1.  Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.

Authors:  M Novella; R Solà; G Soriano; M Andreu; J Gana; J Ortiz; S Coll; M Sàbat; M C Vila; C Guarner; F Vilardell
Journal:  Hepatology       Date:  1997-03       Impact factor: 17.425

2.  Definition and determination of in vitro antibiotic susceptibility breakpoints for bacteria in France. The Comité de l'Antibiogramme de la Société Française de Microbiologie.

Authors:  C J Soussy; R Cluzel; P Courvalin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-03       Impact factor: 3.267

3.  Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study.

Authors:  R Terg; S Cobas; E Fassio; G Landeira; B Ríos; W Vasen; R Abecasis; H Ríos; M Guevara
Journal:  J Hepatol       Date:  2000-10       Impact factor: 25.083

4.  Monomicrobial nonneutrocytic bacterascites: a variant of spontaneous bacterial peritonitis.

Authors:  B A Runyon
Journal:  Hepatology       Date:  1990-10       Impact factor: 17.425

5.  Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients.

Authors:  E Ricart; G Soriano; M T Novella; J Ortiz; M Sàbat; L Kolle; J Sola-Vera; J Miñana; J M Dedéu; C Gómez; J L Barrio; C Guarner
Journal:  J Hepatol       Date:  2000-04       Impact factor: 25.083

6.  Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study.

Authors:  A Rimola; J M Salmerón; G Clemente; L Rodrigo; A Obrador; M L Miranda; C Guarner; R Planas; R Solá; V Vargas
Journal:  Hepatology       Date:  1995-03       Impact factor: 17.425

7.  A prospective study of bacterial infections in patients with cirrhosis.

Authors:  W R Caly; E Strauss
Journal:  J Hepatol       Date:  1993-07       Impact factor: 25.083

8.  Inoculation of blood culture bottles with ascitic fluid. Improved detection of spontaneous bacterial peritonitis.

Authors:  B A Runyon; E T Umland; T Merlin
Journal:  Arch Intern Med       Date:  1987-01

9.  The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding.

Authors:  W J Hsieh; H C Lin; S J Hwang; M C Hou; F Y Lee; F Y Chang; S D Lee
Journal:  Am J Gastroenterol       Date:  1998-06       Impact factor: 10.864

10.  Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial.

Authors:  J D Grangé; D Roulot; G Pelletier; E A Pariente; J Denis; O Ink; P Blanc; J P Richardet; J P Vinel; F Delisle; D Fischer; A Flahault; X Amiot
Journal:  J Hepatol       Date:  1998-09       Impact factor: 25.083

View more
  16 in total

1.  Clostridium perfringens spontaneous bacterial peritonitis: report of a case and implications for management.

Authors:  Patrick E Young; Richard R Dobhan; Theodore W Schafer
Journal:  Dig Dis Sci       Date:  2005-06       Impact factor: 3.199

2.  Genetic diversity and virulence profiles of Escherichia coli isolates causing spontaneous bacterial peritonitis and bacteremia in patients with cirrhosis.

Authors:  Frédéric Bert; James R Johnson; Bénédicte Ouattara; Véronique Leflon-Guibout; Brian Johnston; Estelle Marcon; Dominique Valla; Richard Moreau; Marie-Hélène Nicolas-Chanoine
Journal:  J Clin Microbiol       Date:  2010-06-02       Impact factor: 5.948

3.  The new epidemiology of nosocomial bacterial infections in cirrhosis: therapeutical implications.

Authors:  Juan Acevedo; Aníbal Silva; Verónica Prado; Javier Fernández
Journal:  Hepatol Int       Date:  2012-08-14       Impact factor: 6.047

4.  Diagnosis and management of bacterial infections in decompensated cirrhosis.

Authors:  Maria Pleguezuelo; Jose Manuel Benitez; Juan Jurado; Jose Luis Montero; Manuel De la Mata
Journal:  World J Hepatol       Date:  2013-01-27

5.  Comparative Study of Community Acquired and Nosocomial Spontaneous Bacterial Peritonitis and its Variants in 150 Patients.

Authors:  Girisha Balaraju; Mallikarjun Patil; Adarsh C Krishnamurthy; Dheeraj Karanth; Harshad Devarbhavi
Journal:  J Clin Exp Hepatol       Date:  2017-03-20

6.  Spontaneous bacterial peritonitis in patients with hepatitis B virus-related liver cirrhosis: community-acquired versus nosocomial.

Authors:  Seung Up Kim; Young Eun Chon; Chun Kyon Lee; Jun Yong Park; Do Young Kim; Kwang-Hyub Han; Chae Yoon Chon; Sinyoung Kim; Kyu Sik Jung; Sang Hoon Ahn
Journal:  Yonsei Med J       Date:  2012-03       Impact factor: 2.759

7.  Prognostic significance of infection acquisition sites in spontaneous bacterial peritonitis: nosocomial versus community acquired.

Authors:  Joon Young Song; Seong Ju Jung; Cheong Won Park; Jang Wook Sohn; Woo Joo Kim; Min Ja Kim; Hee Jin Cheong
Journal:  J Korean Med Sci       Date:  2006-08       Impact factor: 2.153

Review 8.  Management of Infectious Complications Associated with Acute-on-Chronic Liver Failure.

Authors:  Cornelius Engelmann; Thomas Berg
Journal:  Visc Med       Date:  2018-07-27

9.  Antimicrobial resistance in patients with decompensated liver cirrhosis and bacterial infections in a tertiary center in Northern Germany.

Authors:  Annika Hillert; Marie Schultalbers; Tammo L Tergast; Ralf-Peter Vonberg; Jessica Rademacher; Heiner Wedemeyer; Markus Cornberg; Stefan Ziesing; Benjamin Maasoumy; Christoph Höner Zu Siederdissen
Journal:  BMC Gastroenterol       Date:  2021-07-20       Impact factor: 3.067

10.  Use of the delta neutrophil index as a prognostic factor of mortality in patients with spontaneous bacterial peritonitis: implications of a simple and useful marker.

Authors:  Tae Seop Lim; Beom Kyung Kim; Jong Wook Lee; Young Ki Lee; Sooyun Chang; Seung Up Kim; Do Young Kim; Sang Hoon Ahn; Kwang-Hyub Han; Chae Yoon Chon; Jun Yong Park
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.